The People of PaxMed
Working with the PaxMed team means you’re working with experts in regulatory affairs, quality assurance, clinical trials, biocompatibility, biomaterials, and implantable devices. Based on your needs, a team will be tailored to ensure that your specific project is successful.
Floyd G. Larson, M.S., M.B.A. – President
Floyd oversees all projects and acts as a key liaison between our clients and regulatory agencies. Floyd’s educational background in chemistry, materials science, and business management prepared him for a career in science-based regulatory affairs. Before founding PaxMed, he was Vice President, Scientific Affairs for a major implantable medical device company. Floyd currently serves as Membership Secretary of ASTM International Committee F04 on Medical Devices and is Chairman of ISO/TC 106 Subcommittee 8 on Dental Implants, as well as head of the U.S. delegation to the Subcommittee. He is a member of the American Dental Association’s Standards Committee on Dental Products. He also serves as Convener of the ISO working group responsible for standards for mechanical characterization of dental implants. He has served as the Industry Representative to the Dental Products Panel of the FDA Medical Devices Advisory Committee, and has authored and coauthored industry-related articles. Floyd was named one of Medical Device & Diagnostic Industry Magazine’s 100 Notable People in the medical device industry.
Kevin A. Thomas, Ph.D. – Vice President and Director of Regulatory Affairs
Kevin is responsible for providing oversight for all regulatory projects, including strategy, personnel, budgets, and timelines. He is actively involved in
Ellen R. Esterline, M.A. – Senior Quality Systems Specialist
Ellen specializes in helping medical device companies face challenging compliance issues in both
Christine L. Peterson, B.A. – Director of Clinical Studies
Christine directs our Clinical Studies Department with overall responsibility for study management, the monitoring staff, and ensuring appropriate reporting of the study. With her training in clinical trial management and her more than 14 years of Investigational Device Exemption (IDE) and post-market clinical trial experience, she provides the in-house study leadership. This includes the initial writing of the protocol and study materials, working with the staff and the client to clarify the study goals and to meet FDA’s requirements. Christine also leads clinical study training, including the design and conduct for initial and on-going training of study center personnel and monitors, and coordinates the FDA relationships and reporting requirements.
Claudia H. Fell, B.S. – Office Manager
Claudia is in charge of office administration, assists with document archiving and spearheads production of all regulatory submissions. She provides oversight of the myriad day-to-day
Jim Duvall, B.A., M.M., M.C.M – Manager of Business Administration & Development
As the initial responder to our prospective clients, Jim manages PaxMed’s business development and works with PaxMed consultants to initiate new projects from companies around the globe. Our clients are seeking to market their medical devices in the United States and in Europe and he monitors progress on submissions to ensure that optimal business flows are achieved. An integral part of his responsibilities includes managing financial matters with our clients. Jim comes to us with several years of accounting, project management, and enterprise management experience, both in corporate and small business entities.